Dexcom Investor
![](/files/companies/Dexcom.png)
Dexcom's goal is to simplify and improve diabetes management by using Continuous Glucose Management (CGM). Designed to keep track of glucose levels.
Investors
Headquarters:
San Diego
Industry:
manufacturing
Employee Number:
7600
Estimated Revenue:
US$ 3.62 billion
Investors Number:
7
Investor Type:
For Profit
Funding Status:
IPO
Acquisitions Number:
3
Number Of Exists:
1
Technology:
AgeTech
Last Funding Type:
Post-IPO Debt
Founded Date:
1999-05-22
Total Funding:
413689019
Last Funding Date:
2017